Literature DB >> 29643129

Vessel Stretching Is a Cause of Lumen Enlargement Immediately After Balloon Pulmonary Angioplasty: Intravascular Ultrasound Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Hiroto Shimokawahara1, Aiko Ogawa1, Hiroki Mizoguchi1, Hiroki Yagi1, Hidekazu Ikemiyagi1, Hiromi Matsubara2.   

Abstract

BACKGROUND: Balloon pulmonary angioplasty (BPA) has become an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary endarterectomy. We retrospectively investigated intravascular ultrasound measurements to elucidate how the lumen enlarges immediately after BPA. METHODS AND
RESULTS: A total of 326 lesions in 71 patients with chronic thromboembolic pulmonary hypertension were analyzed. The cross-sectional areas (CSAs) of the external elastic membrane and lumen measured by intravascular ultrasound before and after BPA were assessed for each lesion type (type A, ring-like stenosis lesions; type B, web lesions; type C, subtotal occlusion lesions). Comparing the lesion types, the proportion of the area occupied by fibrous tissue was smallest in the type A lesions and largest in the type C lesions. The mean lesion lumen CSA was increased after BPA because of an increase in external elastic membrane CSA (from 23.2±12.9 to 27.2±14.3 mm2; P<0.001) with a slight decrease in fibrous tissue plus media CSA (from 17.7±11.7 to 17.3±11.1 mm2; P<0.001). The change in lumen CSA correlated strongly with the change in external elastic membrane CSA (r2=0.762; P<0.001).
CONCLUSIONS: Lumen enlargement immediately after BPA was obtained by the overall vessel expansion induced by a stretch of the arterial wall. In addition, the amount of fibrous tissue depended on each lesion type. Thus, it might be beneficial to change the balloon size to correspond with the lesion type.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  angiography; angioplasty, balloon; hypertension, pulmonary; thrombosis

Mesh:

Year:  2018        PMID: 29643129     DOI: 10.1161/CIRCINTERVENTIONS.117.006010

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  6 in total

Review 1.  Balloon Pulmonary Angioplasty as a Treatment in Chronic Thromboembolic Pulmonary Hypertension: Past, Present, and Future.

Authors:  Panagiotis Karyofyllis; Eftychia Demerouti; Varvara Papadopoulou; Vassilis Voudris; Hiromi Matsubara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-02-13

2.  Circulatory disturbance of the cochlear spiral modiolar artery in a type 2 diabetic mouse model.

Authors:  Young Joon Seo; Dae Bo Shim; Arazu Sharif; Zeke Samson; Ryu Takechi; Daniel Brown
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-09

3.  Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Authors:  Wojciech Magoń; Jakub Stępniewski; Marcin Waligóra; Kamil Jonas; Roman Przybylski; Piotr Podolec; Grzegorz Kopeć
Journal:  Cells       Date:  2022-04-29       Impact factor: 7.666

4.  Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.

Authors:  Taek Kyu Park; Seung Hun Lee; Ki Hong Choi; Joo Myung Lee; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

Review 5.  Balloon Pulmonary Angioplasty: State of the Art.

Authors:  John G Coghlan; Alexander Mk Rothman; Stephen P Hoole
Journal:  Interv Cardiol       Date:  2021-02-15

6.  The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension.

Authors:  Masao Takigami; Hideo Tsubata; Naohiko Nakanishi; Yuki Matsubara; Noriyuki Wakana; Kenji Yanishi; Kan Zen; Takeshi Nakamura; Satoaki Matoba
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.